tiprankstipranks

Sung Lee Insider Profile

4 Followers
Sung Lee, EVP & CFO at Sangamo Therapeutics, holds 63.22K shares in Cytokinetics (Ticker: CYTK), holds 22.87K shares in Tango Therapeutics (Ticker: TNGX), holds 100.49K shares in Vir Biotechnology (Ticker: VIR).
tipranks
Sung Lee

Sung Lee
Sangamo Therapeutics (SGMOQ)
EVP & CFO

Ranked #59,794 out of 108,136 Corporate Insiders

Profitable Transactions

50%
3 out of 6 Profitable Transactions

Average Return

-2.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$7M
76.40%
14.10%
9.41%
0.09%
A breakdown of Sung Lee's holdings

Insider Roles

Cytokinetics
(CYTK)
EVP & CFO
Vir Biotechnology
(VIR)
EVP & CFO
Tango Therapeutics
(TNGX)
Director
Sangamo Therapeutics
(SGMOQ)
EVP & CFO
Roles that Sung Lee holds in companies

Most Profitable Insider Trade

Stock:
Vir Biotechnology
(VIR)
Rating:Informative Sell
Date:Mar 28, 2024 - Mar 28, 2025
Return:+33.80%
The most profitable trade made by Sung Lee

Sung Lee's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Sangamo Therapeutics
Nov 30, 2020
EVP & CFO
Uninformative Sell
49.26K
$6.56K
Vir Biotechnology
Mar 28, 2024
EVP & CFO
Informative Sell
59.36K
$1.01M
Cytokinetics
Jul 02, 2026
EVP & CFO
Uninformative Buy
53.94K
$5.47M
Tango Therapeutics
Jun 08, 2026
Director
Uninformative Buy
$673.75K
List of latest transactions for each holding click on a transaction to see Sung Lee's performance on stock

Sung Lee insider profile FAQ

What is the percentage of profitable transactions made by Sung Lee?
The percentage of profitable transactions made by Sung Lee is 50%.
    What is the average return per transaction made by Sung Lee?
    The average return per transaction made by Sung Lee is -2.60%.
      What stocks does Sung Lee hold?
      Sung Lee holds: SGMOQ, VIR, CYTK, TNGX stocks.
        What was Sung Lee’s latest transaction?
        Sung Lee latest transaction was an Uninformative Buy of $53.94K.
          What was Sung Lee's most profitable transaction?
          Sung Lee’s most profitable transaction was an Informative Sell of VIR stock on March 28, 2024. The return on the trade was 33.80%.
            What is Sung Lee's role in Sangamo Therapeutics?
            Sung Lee's role in Sangamo Therapeutics is EVP & CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.